Granahan Investment Management’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $11.7M | Sell |
|
|||||
|
2021
Q2 | $10.1M | Buy |
|
|||||
|
2021
Q1 | $10.4M | Buy |
|
|||||
|
2020
Q4 | $7.48M | Sell |
|
|||||
|
2020
Q3 | $13.1M | Sell |
|
|||||
|
2020
Q2 | $12.8M | Sell |
|
|||||
|
2020
Q1 | $13.2M | Sell |
|
|||||
|
2019
Q4 | $11.2M | Sell |
|
|||||
|
2019
Q3 | $8.5M | Buy |
|
|||||
|
2019
Q2 | $8.4M | Sell |
|
|||||
|
2019
Q1 | $10.2M | Sell |
|
|||||
|
2018
Q4 | $10.2M | Sell |
|
|||||
|
2018
Q3 | $13.6M | Buy |
|
|||||
|
2018
Q2 | $11M | Sell |
|
|||||
|
2018
Q1 | $9.1M | Buy |
|
|||||
|
2017
Q4 | $9.6M | Buy |
|
|||||
|
2017
Q3 | $8.1M | Buy |
|
|||||
|
2017
Q2 | $5.72M | Buy |
|
|||||
|
2017
Q1 | $4.95M | Sell |
|
|||||
|
2016
Q4 | $17.4M | Sell |
|
|||||
|
2016
Q3 | $29.6M | Buy |
|
|||||
|
2016
Q2 | $25.8M | Buy |
|
|||||
|
2016
Q1 | $19.1M | Buy |
|
|||||
|
2015
Q4 | $32M | Buy |
|
|||||
|
2015
Q3 | $12.2M | Buy |
|
|||||
|
2015
Q2 | $14.8M | Sell |
|
|||||
|
2015
Q1 | $17.9M | Buy |
|
|||||
|
2014
Q4 | $11.9M | Buy |
|